U-awards support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. These awards are termed Cooperative Agreements. The U-series is a funding program that an individual scientist receives, although the scientist still works in cooperation with federal employees. This mechanism is used when substantial programmatic involvement is anticipated between the awarding Institute and Center. According to the National Institutes of Health, a cooperative agreement includes characteristics of a research grant and a contract job. With a federal contract, federal managers take a larger role in administrating the contract and directing the scientists. There is no specific dollar limit unless specified in the funding opportunity announcement (FOA).
There are 81 different U-series award types listed on the NIH website. Some are very specific with narrow objectives, such as the U11, which is titled “Study (in China) of Periconceptional Vitamin Supplements to Prevent Spina Bifida and Anencephaly Cooperative Agreements”. This Webinar will focus on those having the most relevance to a diverse crowd of biomedical researchers. For example,the U01 mechanism is particularly appropriate if you are considering a project involving pre-clinical testing of novel drugs or some other type of treatment modality. Likewise, the U10 supports clinical evaluation of various methods of therapy and/or prevention in specific disease areas. Also covered will be the U43 and U44 awards, which support projects that may ultimately lead to commercial products or services, and several selected other U-series award types.
During this educational Webinar, your expert presenter will cover the specifics of the application process, the differences between a grant and a cooperative agreement, milestone driven research, and highlighting strategies to best position your application for successfully being awarded funds.